Aptar Pharma Unveils PureHale in Latin America during FCE Pharma 2019, São Paulo, Brazil

Aptar Pharma is pleased to be a key exhibitor at this year’s FCE Pharma exhibition, taking place from May 21-23 at the São Paulo Expo, Sao Paulo, Brazil.

Aptar Pharma has been exhibiting at this key industry event for a number of years and is looking forward to once again sharing our latest innovations at this year’s show.

At Booth No. H021, Hall H, visitors are invited to meet with our drug delivery experts, who will be on hand to present Aptar Pharma’s expanding portfolio of drug delivery solutions and technology innovations across nasal, pulmonary, eye care, dermal and injectable routes.

A highlight of our presence at FCE Pharma 2019 will be the unveiling of Aptar Pharma’s PureHale for the first time in Latin America.  PureHale is a portable and ready-to-use nebulizer-like device, designed to deliver natural care to upper airways.

With growing customer interest in the Latin American market for preservative-free formulations, visitors to the Aptar Pharma booth will have the opportunity to find out more about our Ophthalmic Squeeze Dispense (OSD).  With more than 200 market references worldwide, the Aptar Pharma Ophthalmic Squeeze Dispenser is the first and only FDA approved preservative-free dispensing technology, is suitable for a wide range of viscosities, and was recently approved across Europe for Glaucoma prescription treatment.

FCE Pharma is considered the key annual pharmaceutical and cosmetics tradeshow in Latin America, bringing together all the major players in the pharmaceutical industry to share their knowledge and expertise, exchange ideas and showcase the latest trends and innovations. More than 23,000 visitors are expected to attend this year’s event.

Visit Aptar Pharma at FCE Pharma 2019.  We look forward to welcoming you.